{"text": ["Pfizer", "(PFE)", "Stock", "Sinks", "As", "Market", "Gains:", "What", "You", "Should", "Know"], "created_at": "2020-01-13 22:45:10"}
{"text": ["Top", "Pharmaceutical", "Stocks", "for", "Q1", "2020"], "created_at": "2020-01-13 18:31:13"}
{"text": ["Is", "Pfizer", "(PFE)", "Stock", "Outpacing", "Its", "Medical", "Peers", "This", "Year?"], "created_at": "2020-01-13 16:30:04"}
{"text": ["Glaxo", "Files", "Marketing", "Application", "for", "Fostemsavir", "in", "Europe"], "created_at": "2020-01-13 15:26:03"}
{"text": ["In", "time", "for", "biotech's", "biggest", "conference,", "Union", "Square", "costs", "climb"], "created_at": "2020-01-13 14:46:51"}
{"text": ["Nektar", "Up", "25%", "as", "Bristol-Myers", "Expands", "Bempeg", "Collaboration"], "created_at": "2020-01-13 14:14:02"}
{"text": ["Benzinga", "Pro's", "Top", "5", "Stocks", "To", "Watch", "For", "Mon.,", "Jan.", "13,", "2020:", "WCC,", "LULU,", "XLF,", "TEAM,", "BIIB"], "created_at": "2020-01-13 13:46:39"}
{"text": ["Biogen", "to", "buy", "from", "Pfizer", "an", "asset", "to", "develop", "into", "potential", "Alzheimer's,", "Parkinson's", "treatments"], "created_at": "2020-01-13 12:51:00"}
{"text": ["Biogen", "to", "Acquire", "Novel", "Clinical", "Stage", "Asset", "with", "Application", "in", "Alzheimer\u2019s", "Disease", "and", "Parkinson\u2019s", "Disease", "from", "Pfizer", "Inc."], "created_at": "2020-01-13 12:30:10"}
{"text": ["Axsome", "Therapeutics", "Enters", "into", "Exclusive", "License", "Agreement", "with", "Pfizer", "Inc.", "for", "Pfizer\u2019s", "Reboxetine", "Clinical", "and", "Nonclinical", "Data", "and", "for", "New", "Phase", "3", "Esreboxetine", "Product", "Candidate"], "created_at": "2020-01-13 11:00:10"}
